Transnetyx, INC.:1183655 [22-004074] genotyping for DR. LIN's lab
Ended Awarded Last action
- Contract number
- 75N95022F00113
- Awardee
-
Transnetyx, Inc. UEI CNG6DGADGL38
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$20,000 | |
| Original award | $20,000 |
Quick answers
Who was awarded contract 75N95022F00113?
75N95022F00113 was awarded to Transnetyx, Inc. by National Institute on Drug Abuse (National Institutes of Health) on June 26, 2022.
How much is contract 75N95022F00113 worth?
The government has obligated $0 on 75N95022F00113.
Is contract 75N95022F00113 an order under another contract?
Yes. 75N95022F00113 is a BPA call under HHSN263201100002B, a blanket purchase agreement.
Was contract 75N95022F00113 competed?
The extent of competition for 75N95022F00113 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award